Chitosan is a natural biopolymer produced by deacetylating chitin extracted from crustacean shells, fungal cell walls or other biological sources, and it is supplied as powder, flakes or liquid solutions across a range of molecular weights and purity grades. It functions as a flocculant and coagulant in water treatment, a film-forming and preservative agent in food and packaging, a carrier in agricultural biostimulant and biopesticide products, and a biocompatible excipient in pharmaceutical and cosmetic formulations. Buyers include water treatment operators, food and beverage processors, agricultural input formulators, and pharmaceutical, biomedical and personal-care manufacturers who select grade and molecular weight to match their intended application.
Expansion of water and wastewater treatment demand
Expansion of water and wastewater treatment demand is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 13.5% a year, the application lines exposed to it move fastest: Pharmaceutical compounds at 16.9%, taking its share of revenue from 15.98% to 21% and its value from USD 3 billion to USD 12.31 billion.
The study also runs a bull case: the bull case assumes wastewater discharge regulations tighten faster than currently scheduled across Asia Pacific and Europe, pharmaceutical-grade approvals for chitosan-based wound care and drug-delivery products clear on the earlier end of their pipelines, and fungal-source capacity expands quickly enough to remove the shell-feedstock supply constraint years ahead of the base case. That path ends 2034 at USD 69.17 billion, above the USD 58.62 billion base case.
On the downside, the bear case assumes wastewater-treatment regulatory enforcement slips or is delayed in key markets, synthetic and alternative biopolymer substitutes hold their price advantage in industrial-grade applications longer than expected, and crustacean-shell feedstock costs rise enough to compress margins and slow capacity additions, which would hold 2034 revenue to USD 48.07 billion. Water & Wastewater Treatment, which carries 26% of 2025 revenue, already grows at only 12.48% against the market's 13.5%, so the largest part of the base is also its slowest.
The Competitive Split Runs by Application
Competition in the global chitosan and chitosan derivatives market runs along the application axis, not the regional one. Water & Wastewater Treatment holds 26% of 2025 revenue at USD 4.88 billion and remains the largest line through 2034 at 24%, making it the position hardest for a challenger to take. Pharmaceutical, growing at 16.9%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 18.76 billion.
Further Report Findings
* * * Water & Wastewater Treatment was the leading application line in 2025, taking 26% of revenue at USD 4.88 billion. * The fastest application line is Pharmaceutical, forecast to compound at 16.9% through the period. * By source, Crustacean Shell led in 2025 with 81.98% of revenue at USD 15.38 billion, while Fungal grows fastest at 17.99%. * By form, Powder led in 2025 with 58% of revenue at USD 10.88 billion, while Liquid/Solution grows fastest at 17.84%. * By grade, Industrial Grade led in 2025 with 39.98% of revenue at USD 7.5 billion, while Pharmaceutical Grade grows fastest at 17.17%. * By molecular weight, Medium Molecular Weight led in 2025 with 44.99% of revenue at USD 8.44 billion, while High Molecular Weight grows fastest at 16.88%. * China is the largest single country market at USD 4.09 billion in 2025, 21.8% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by application, and by source, form, grade and molecular weight. The headline total carries bear, base and bull cases at USD 48.07 billion and USD 69.17 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.